Niti Aayog V.K.Paul city New Delhi India covid-19 testing vaccine infection Niti Aayog V.K.Paul city New Delhi India

India not to fix a benchmark in selecting covid-19 vaccine

Reading now: 442
www.livemint.com

NEW DELHI : India is not planning to follow a preset benchmark for selecting a covid-19 vaccine and will explore all available options for mass immunization against the contagion, which has killed more than 53,000, and infected over 2.8 million in the country.Central government officials said they were considering various benchmarks, such as cost, ease of administration and efficacy, to determine the vaccine candidates.“When we will have a vaccine ready, we will look at all parameters in a balanced manner, how effective it is, what is the cost, ease of administration, besides other factors," said Dr V.K.

Paul, NITI Aayog member (health), and the chairman of the National Expert Group on Vaccine Administration.“Of course, if it has an.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA